{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:55:10Z","timestamp":1761663310234},"reference-count":25,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:p>The high mortality rates associated with candidemia episodes and the emergence of resistance to antifungal agents necessitate the monitoring of the susceptibility of fungal isolates to antifungal treatments. The new, recently approved, species-specific clinical breakpoints (SS-CBPs)(M27-S4) for evaluating susceptibility require careful interpretation and comparison with the former proposals made using the M27-A3 breakpoints, both from CLSI. This study evaluated the susceptibility of the different species of Candida that were isolated from candidemias based on these two clinical breakpoints. Four hundred and twenty-two isolates were identified and, among them, C. parapsilosis comprised 46.68%, followed by C. albicans (35.78%), C. tropicalis (9.71%), C. glabrata (3.55%), C. lusitaniae (1.65%), C. guilliermondii (1.65%) and C. krusei (0.94%). In accordance with the M27-A3 criteria, 33 (7.81%) non-susceptible isolates were identified, of which 16 (3.79%) were resistant to antifungal agents. According to SS-CBPs, 80 (18.95%) isolates were non-susceptible, and 10 (2.36%) of these were drug resistant. When the total number of non-susceptible isolates was considered, the new SS-CBPs detected 2.4 times the number of isolates that were detected using the M27-A3 interpretative criteria. In conclusion, the detection of an elevated number of non-susceptible species has highlighted the relevance of evaluating susceptibility tests using new, species-specific clinical breakpoints (SS-CBPs), which could impact the profile of non-susceptible Candida spp. to antifungal agents that require continuous susceptibility monitoring.<\/jats:p>","DOI":"10.1590\/s0036-46652014000600004","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T19:13:20Z","timestamp":1414005200000},"page":"477-482","source":"Crossref","is-referenced-by-count":32,"title":["SUSCEPTIBILITY OF Candida spp. ISOLATED FROM BLOOD CULTURES AS EVALUATED USING THE M27-A3 AND NEW M27-S4 APPROVED BREAKPOINTS"],"prefix":"10.1590","volume":"56","author":[{"given":"Edileusa Rosa dos","family":"Santos","sequence":"first","affiliation":[{"name":"Federal University of Santa Maria,  Brazil; University Hospital of Santa Maria,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila F. Dal","family":"Forno","sequence":"additional","affiliation":[{"name":"University Hospital of Santa Maria,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari Glei","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Federal University of Santa Maria,  Brazil; University Hospital of Santa Maria,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tha\u00eds Felli","family":"Kubi\u00e7a","sequence":"additional","affiliation":[{"name":"Federal University of Santa Maria,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarcieli P.","family":"Venturini","sequence":"additional","affiliation":[{"name":"Federal University of Santa Maria,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francieli","family":"Chassot","sequence":"additional","affiliation":[{"name":"Federal University of Santa Maria,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janio M.","family":"Santurio","sequence":"additional","affiliation":[{"name":"Federal University of Santa Maria,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney Hartz","family":"Alves","sequence":"additional","affiliation":[{"name":"Federal University of Santa Maria,  Brazil; Federal University of Santa Maria,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of <em>Candida<\/em> bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003","volume":"43","author":"Almirante B","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1590\/S0036-46652004000500001","article-title":"Candidemia in a Brazilian tertiary care hospital: species distribution and antifungal susceptibility patterns","volume":"46","author":"Antunes AGV","year":"2004","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1590\/S1413-86702005000500009","article-title":"Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil","volume":"9","author":"Aquino VR","year":"2005","journal-title":"Braz J Infect Dis"},{"key":"ref4","year":"2008"},{"key":"ref5","year":"2012"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/JCM.00773-06","article-title":"Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers","volume":"44","author":"Colombo AL","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.diagmicrobio.2006.10.011","article-title":"Antifungal susceptibility of 1000 <em>Candida<\/em> bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in S\u00e3o Paulo, Brazil, 1995-2003","volume":"57","author":"Da Matta DA","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref8","series-title":"Interactions of yeasts, moulds, and antifungal agents: how to detect resistance","first-page":"131","volume-title":"Utility of antifungal susceptibility testing and clinical correlations","author":"Diekema DJ","year":"2012"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1590\/S0037-86822008000100005","article-title":"Candidemia em um hospital terci\u00e1rio brasileiro: incid\u00eancia, freq\u00fc\u00eancia das diferentes esp\u00e9cies, fatores de risco e suscetibilidade aos antif\u00fangicos","volume":"41","author":"Fran\u00e7a JCB","year":"2008","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1590\/S0037-86822008000400014","article-title":"Candidemia em hospital terci\u00e1rio no nordeste do Brasil","volume":"41","author":"Hinrichsen SL","year":"2008","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1128\/JCM.02363-09","article-title":"<em>Candida<\/em> Surveillance Study Investigators. Antifungal susceptibility testing of <em>Candida<\/em> isolates from the <em>Candida<\/em> surveillance study","volume":"48","author":"Lyon GM","year":"2010","journal-title":"J Clin Microbiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1128\/JCM.02434-08","article-title":"Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against <em>Candida<\/em> spp., <em>Cryptococcus<\/em> spp., and <em>Aspergillus<\/em> spp.: report from the SENTRY Antimicrobial Surveillance program (2006-2007)","volume":"47","author":"Messer SA","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref13","year":"1997"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10096-004-1104-x","article-title":"Economic impact of <em>Candida<\/em> colonization and <em>Candida<\/em> infection in the critically ill patients","volume":"23","author":"Olaechea PM","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas PG","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11046-005-3452-1","article-title":"A 9-year study comparing risk factors and outcome of pediatric and adults with nosocomial candidaemia","volume":"160","author":"Pasqualotto AC","year":"2005","journal-title":"Mycopathologia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10096-004-1267-5","article-title":"Epidemiology and antifungal susceptibility of <em>Candida<\/em> species isolated from blood: results of a 2 -year multicenter study in Spain","volume":"24","author":"Pem\u00e1n J","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1586\/eri.09.18","article-title":"Antifungal drug resistance mechanisms","volume":"7","author":"Pem\u00e1n J","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3109\/13693780903580121","article-title":"Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-<em>C. albicans Candida<\/em> species","volume":"48","author":"Pereira GH","year":"2010","journal-title":"Med Mycol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller MA","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1128\/JCM.01551-06","article-title":"Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of <em>Candida<\/em> spp. tested by clinical and laboratory standards institute-recommended broth microdilution methods","volume":"45","author":"Pfaller MA","year":"2007","journal-title":"J Clin Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","article-title":"Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and <em>Candida<\/em>: time for harmonization of CLSI and EUCAST broth microdilution methods","volume":"13","author":"Pfaller MA","year":"2010","journal-title":"Drug Resist Updat"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijantimicag.2011.02.016","article-title":"<em>Candida<\/em> bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008\u20132009)","volume":"38","author":"Pfaller MA","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"ref24","first-page":"2846","article-title":"Progress in antifungal susceptibility testing of <em>Candida<\/em> spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012","volume":"2012","author":"Pfaller MA","journal-title":"J Clin Microbiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","article-title":"EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts","volume":"14","author":"Rodriguez-Tudela JL","year":"2008","journal-title":"Clin Microbiol Infect"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v56n6\/0036-4665-rimtsp-56-06-477.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T18:21:23Z","timestamp":1495909283000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652014000600477&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0036-46652014000600477"],"URL":"https:\/\/doi.org\/10.1590\/s0036-46652014000600004","relation":{},"ISSN":["0036-4665"],"issn-type":[{"value":"0036-4665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}